Multiple Myeloma  >>  pegylated liposomal doxorubicin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pegylated liposomal doxorubicin / Generic mfg.
NCT00091624: A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)

Completed
1
77
US
CC-5013
Celgene Corporation
Multiple Myeloma
09/07
09/07
NCT00744354: Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma

Terminated
1
32
US
bortezomib, Velcade, pegylated liposomal doxorubicin hydrochloride, Doxil, vorinostat, Zolinza
UNC Lineberger Comprehensive Cancer Center, Merck Sharp & Dohme LLC, Millennium Pharmaceuticals, Inc., Ortho Biotech, Inc.
Multiple Myeloma and Plasma Cell Neoplasm
12/11
04/15
NCT01371227: A Study of JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma

Completed
1
3
Japan
JNS002
Janssen Pharmaceutical K.K.
Multiple Myeloma
05/12
05/12

Download Options